Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The platelet-derived growth factor receptor (PDGFR) tyrosine kinase family is a group of cell surface receptors that play a crucial role in cellular signaling, particularly in the regulation of cell growth, survival, and development. These receptors are part of the type III receptor tyrosine kinase (RTK) family and include two main isoforms: PDGFRα and PDGFRβ. Ligands include PDGF-A, PDGF-B, PDGF-C and PDGF-D, forming homo- or heterodimers that activate the receptors. Activation leads to autophosphorylation and downstream signaling, influencing cell proliferation, migration, and differentiation. Dysregulation is associated with diseases like cancer, atherosclerosis, and fibrotic conditions.
Inhibition of receptor tyrosine kinase activity, blocking downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet-derived Growth Factor Receptor Tyrosine Kinase Family (PDGFR Tyrosine Kinase Family).